Geode Capital Management LLC Grows Stake in Inogen, Inc. (NASDAQ:INGN)

Geode Capital Management LLC lifted its position in Inogen, Inc. (NASDAQ:INGN) by 1.1% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 554,191 shares of the medical technology company’s stock after purchasing an additional 5,921 shares during the quarter. Geode Capital Management LLC’s holdings in Inogen were worth $5,377,000 at the end of the most recent quarter.

Other large investors also recently added to or reduced their stakes in the company. Bank of New York Mellon Corp boosted its stake in Inogen by 8.1% in the second quarter. Bank of New York Mellon Corp now owns 97,132 shares of the medical technology company’s stock worth $790,000 after buying an additional 7,240 shares in the last quarter. Monaco Asset Management SAM bought a new position in shares of Inogen in the second quarter worth approximately $610,000. American Century Companies Inc. increased its stake in shares of Inogen by 33.2% in the second quarter. American Century Companies Inc. now owns 38,627 shares of the medical technology company’s stock worth $314,000 after buying an additional 9,626 shares during the period. Meeder Asset Management Inc. purchased a new position in shares of Inogen in the second quarter worth $30,000. Finally, XTX Topco Ltd bought a new stake in Inogen during the 2nd quarter valued at $178,000. Institutional investors own 89.94% of the company’s stock.

Wall Street Analysts Forecast Growth

INGN has been the subject of several recent analyst reports. Needham & Company LLC reiterated a “hold” rating on shares of Inogen in a report on Friday, November 8th. StockNews.com lowered Inogen from a “buy” rating to a “hold” rating in a research report on Friday, December 20th.

Inogen Trading Up 4.7 %

Shares of Inogen stock opened at $9.62 on Friday. Inogen, Inc. has a 12 month low of $5.08 and a 12 month high of $13.33. The firm has a market capitalization of $229.13 million, a P/E ratio of -4.28 and a beta of 1.02. The business has a fifty day simple moving average of $9.39 and a two-hundred day simple moving average of $9.77.

Inogen Profile

Inogen, Inc, a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.